Nk cells mediate increase of phagocytic activity but not of proinflammatory cytokine (interleukin-6 [IL-6], tumor necrosis factor alpha, and IL-12) production elicited in splenic macrophages by tilorone treatment of mice during acute systemic candidiasis

Clinical and Diagnostic Laboratory Immunology

Volumn 9, Issue 6, 2002, Pages 1282-1294

  Gaforio, José Juan ^a   Ortega, Elena ^a   Algarra, Ignacio ^a   Serrano, María José ^a   Alvarez de Cienfuegos, Gerardo ^a  

^a UNIVERSITY OF JAÉN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

3,6 BIS[2 (DIMETHYLAMINO)ETHOXY] 9H XANTHEN 9 ONE; INTERLEUKIN 12; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; R 10874DA; TILORONE; TILORONE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CELL ACTIVATION; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; INFECTION RESISTANCE; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUDE MOUSE; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; SPLEEN CELL; SURVIVAL;

ACUTE DISEASE; ANIMALS; CANDIDIASIS; CYTOKINES; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERLEUKIN-12; INTERLEUKIN-6; KILLER CELLS, NATURAL; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; PHAGOCYTOSIS; SPLEEN; TILORONE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036844624     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.9.6.1282-1294.2002     Document Type: Article

References (41)

1. Algarra, I., A. Gonzalez, M. Pérez, J. J. Gaforio, and F. Garrido. 1996. Effect of in vivo activation of natural killer (NK) cells by a tilorone analogue on the survival of mice injected intravenously with different experimental murine tumours. Clin. Exp. Immunol. 103:499-505.
2. Algarra, I., E. Ortega, M. J. Serrano, G. Alvarez de Cienfuegos, and J. J. Gaforio. 2002. Suppression of splenic macrophage Candida albicans-phagocytosis following in vivo depletion of natural killer cells in immunocompetent BALB/c mice and T-cell-deficient nude mice. FEMS Immunol. Med. Microbiol. 33:159-163.
3. Algarra, I., M. Pérez, J. J. Gaforio, F. Gasca, and F. Garrido. 1994. In vivo activation of NK cells induces inhibition of lung colonization of H-2 positive and H-2 negative fibrosarcoma tumor clones. Clin. Exp. Metastasis 12:31-36.
4. Algarra, I., M. Pérez, P. Hoglund, J. J. Gaforio, H. G. Ljunggren, and F. Garrido. 1993. Generation and control of metastasis in experimental tumor systems: Inhibition of experimental metastases by a tilorone analogue. Int. J. Cancer 54:518-523.
5. Allendoerfer, R., D. M. Magge, J. G. Smith, L. Bonewald, and J. R. Graybill. 1993. Induction of tumor necrosis factor-α in murine Candida albicans infection. J. Infect. Dis. 167:1168-1172.
6. Ashman, R. B., and J. M. Papadimitriou. 1995. Production and function of cytokines in natural and acquired immunity to Candida albicans infection. Microbiol. Rev. 59:646-672.
7. Aybay, C., and T. Imir. 1996. Tumor necrosis factor (TNF) induction from monocytes/macrophages by Candida species. Immunobiology 196:363-374.
8. Balish, E., T. Warner, C. J. Pierson, D. M. Block, and R. D. Wagner. 2001. Oroesophageal candidiasis is lethal for transgenic mice with combined natural killer and T-cell defects. Med. Mycol. 39:261-268.
9. Brieland, J., D. Essig, G. Jackson, D. Frank, D. Loebenberg, F. Menzel, B. Arnold, B. DiDomenico, and R. Hare. 2001. Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice. Infect. Immun. 69:5046-5055.
10. Cenci, E., A. Mencacci, R. Spaccapelo, L. Tonetti, P. Mosci, K. H. Enssle, P. Puccetti, L. Romani, and F. Bistoni. 1995. T helper cell type 1 (Th1)- and Th2-like responses are present in mice with gastric candidiasis, but protective immunity is associated with Th1 development. J. Infect. Dis. 171:1279-1288.
11. Cenci, E., L. Romani, A. Vecchiarelli, P. Puccetti, and F. Bistoni. 1989. Role of L3T4+ lymphocytes in protective immunity to systemic Candida albicans infection in mice. Infect. Immun. 57:3581-3587.
12. Gomez-Flores, R., J. L. Suo, and R. J. Weber. 1999. Suppression of splenic macrophage functions following acute morphine action in the rat mesencephalon periaqueductal gray. Brain Behav. Immun. 13:212-224.
13. Hamerman, J. A., and A. Aderem. 2001. Functional transitions in macrophages during in vivo infection with Mycobacterium bovis bacillus Calmette-Guérin. J. Immunol. 167:2227-2233.
14. Han, Y., S. Kelm, M. H. Riesselman, P. R. Crocker, and J. E. Culter. 1994. Mouse sialoadhesin is not responsible for Candida albicans yeast cell binding to splenic marginal zone macrophages. Infect. Immun. 62:2115-2118.
15. Jouault, T., C. Fradin, P. A. Trinel, and D. Poulain. 2000. Candida albicans-derived β-1,2-linked mannooligosaccharides induce desensitization of macrophages. Infect. Immun. 68:965-968.
16. Louie, A., A. L. Baltch, R. P. Smith, M. A. Franke, W. J. Ritz, J. K. Singh, and M. A. Gordon. 1994. Tumor necrosis factor alpha has a protective role in a murine model of systemic candidiasis. Infect. Immun. 62:2761-2772.
17. Marconi, P., L. Scaringi, L. Tissi, M. Boccanera, F. Bistoni, E. Bonmassar, and A. Casone. 1985. Induction of natural killer cell activity by inactivated Candida albicans in mice. Infect. Immun. 50:297-303.
18. Marino, M. W., A. Dunn, D. Grail, M. Inglese, Y. Noguchi, E. Richards, A. Jungbluth, H. Wada, M. Moore, B. Williamson, S. Basu, and L. J. Old. 1997. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 94:8093-8098.
19. Mayer, G. D., and R. F. Krueger. 1980. Tilorone hydrochloride and related molecules, p. 187-221. In D. A. Stringfellow (ed.), Interferon and Interferon Inducers: Clinical Applications. Marcel Dekker, New York, N.Y.
20. Nau, G. J., J. F. Richmond, A. Schlesinger, E. G. Jennings, E. S. Lander, and R. A. Young. 2002. Human macrophage activation programs induced by bacterial pathogens. Proc. Natl. Acad. Sci. USA 99:1503-1508.
21. Ortega, E., I. Algarra, M. J. Serrano, G. Alvarez de Cienfuegos, and J. J. Gaforio. 2001. The use of 7-amino-actinomycin D in the analysis of Candida albicans phagocytosis and opsonization. J. Immunol. Methods 253:189-193.
22. Ortega, E., I. Algarra, M. J. Serrano, M. A. de Pablo, G. Alvarez de Cienfuegos, and J. J. Gaforio. 2000. Enhanced resistance to experimental systemic candidiasis in tilorone-treated mice. FEMS Immunol. Med. Microbiol. 28:283-289.
23. Puccetti, P., L. Romani, and F. Bistoni. 1995. A Th1-Th2-like switch in candidiasis: New perspectives for therapy. Trends Microbiol. 3:237-240.
24. Qian, Q., M. A. Jutila, N. van Rooijen, and J. E. Cutler. 1994. Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis. J. Immunol. 152:5000-5008.
25. Riipi, L., and E. Carlson. 1990. Tumor necrosis factor (TNF) is induced in mice by Candida albicans: Role of TNF in fibrinogen increase. Infect. Immun. 58:2750-2754.
26. Romani, L. 1999. Immunity to Candida albicans: Th1, Th2 cells and beyond. Curr. Opin. Microbiol. 2:363-367.
27. + T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J. Exp. Med. 183:1345-1355.
28. Romani, L., A. Mencacci, L. Tonetti, R. Spaccapelo, E. Cenci, P. Puccetti, S. F. Wolf, and F. Bistoni. 1994. IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis. J. Immunol. 153:5167-5175.
29. Romani, L., A. Mencacci, L. Tonetti, R. Spaccapelo, E. Cenci, S. F. Wolf, P. Puccetti, and F. Bistoni. 1994. Interleukin-12 but not IFN-γ production correlates with induction of T helper type-1 phenotype in murine candidiasis. Eur. J. Immunol. 24:909-915.
30. Rosati, E., L. Scaringi, P. Cornacchione, K. Fettucciari, R. Sabatini, R. Rossi, and P. Marconi. 1995. Cytokine response to inactivated Candida albicans in mice. Cell. Immunol. 162:256-264.
31. Salcedo, M., M. Andersson, S. Lemieux, L. van Kaer, B. J. Chambers, and H. G. Ljunggren. 1998. Fine tuning of natural killer cell specificity and maintenance of self tolerance in MHC class I-deficient mice. Eur. J. Immunol. 28:1315-1321.
32. Tilg, H., C. A. Dinarello, and J. W. Mier. 1997. IL-6 and APPs: Anti-inflammatory and immunosuppressive mediators. Immunol. Today 18:428-432.
33. Tzianabos, A. O. 2000. Polysaccharide immunomodulators as therapeutic agents: Structural aspects and biologic function. Clin. Microbiol. Rev. 13:523-533.
34. Van Enckevort, F. H., M. G. Netea, A. R. Hermus, C. G. Sweep, J. F. Meis, J. W. Van der Meer, and B. J. Kullberg. 1999. Increased susceptibility to systemic candidiasis in interleukin-6 deficient mice. Med. Mycol. 37:419-426.
35. Vazquez, N., H. R. Buckley, and T. J. Rogers. 1996. Production of IL-6 and TNF-α by the macrophage-like cell line RAW 264.7 after treatment with a cell wall extract of Candida albicans. J. Interf. Cytok. Res. 16:465-470.
36. Vazquez, N., H. R. Buckley, D. M. Mosser, and T. J. Rogers. 1995. Activation of murine resident peritoneal macrophages by a cell wall extract of Candida albicans. J. Med. Vet. Mycol. 33:385-393.
37. Vazquez-Torres, A., and E. Balish. 1997. Macrophages in resistance to candidiasis. Microbiol. Mol. Biol. Rev. 61:170-192.
38. Vecchiarelli, A., M. Puliti, A. Torasantucci, A. Cassone, and F. Bistoni. 1991. In vitro production of tumor necrosis factor by murine splenic macrophages stimulated with mannoprotein constituents of Candida albicans cell wall. Cell. Immunol. 134:65-76.
39. Wojdani, A., and M. Ghoneum. 1987. In vivo augmentation of natural killer cell activity by Candida albicans. Int. J. Immunopharmacol. 9:827-832.
40. Yamamoto, Y., T. W. Klein, and H. Friedman. 1997. Involvement of mannose receptor in cytokine interleukin-1β (IL-1β), IL-6, and granulocyte-macrophage colony-stimulating factor responses, but not in chemokine macrophage inflammatory protein 1β (MIP-1β), MIP-2, and KC responses, caused by attachment of Candida albicans to macrophages. Infect. Immun. 65:1077-1082.
41. Zunino, S. J., and D. Huding. 1988. Interactions between human natural killer (NK) lymphocytes and yeast cells: Human NK cells do not kill Candida albicans, although C. albicans blocks NK lysis of K562 cells. Infect. Immun. 56:564-569.